Literature DB >> 32172249

Exosomal miRNAs Profile in Children's Nonalcoholic Fatty Liver Disease and the Correlation with Transaminase and Uric Acid.

Xuelian Zhou1, Ke Huang1, Junjun Jia2, Yan Ni1, Jinna Yuan1, Xinyi Liang1, Hu Lin1, Wei Peng1, Wei Wu1, Guanping Dong1, Junfen Fu3.   

Abstract

OBJECTIVE: The incidence of non-alcoholic fatty liver disease (NAFLD) in children increased rapidly. However, the pathogenesis of NAFLD, especially how non-alcoholic fatty liver progress to non-alcoholic steatohepatitis, is still unclear. This study aims to explore the exosomal miRNAs profiles and the underline pathogenesis of child NAFLD.
METHODS: Twenty NAFLD and 20 health control were enrolled in this study. Circulating exosomes were isolated, and RNA sequencing was performed in test set (3 NAFLD/3 Controls). The differentially expressed miRNAs (DEM) were further validated in validation set (17 NAFLD/17 Controls). Spearman correlation -analysis was used to investigate the association between DEM and clinical parameters.
RESULTS: Eighty-two miRNAs were differentially expressed (absolute fold change >2 and p < 0.05) in the 2 groups, they were involved in fat acid metabolism, starch and sucrose metabolism, bile acid metabolism and inflammation. miRNA122-5p, miRNA34a-5p, -miRNA155-5p and miRNA146b-3p were up-regulated in NAFLD group (p < 0.05) and positively correlated with body mass index (r, 0.41-0.59), alanine aminotransferase (r, 0.36-0.52), aspartate transaminase (r, 0.31-0.48) and uric acid (UA, r, 0.51-0.69; p < 0.05).
CONCLUSIONS: Circulating exosomal miRNAs may be involved in the pathogenesis of NAFLD and correlated with transaminase and UA.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Children; Circulating exosome; Non-alcoholic fatty liver disease; miRNA

Mesh:

Substances:

Year:  2020        PMID: 32172249     DOI: 10.1159/000506665

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  2 in total

1.  Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis.

Authors:  Haixia Lin; Kelly E Mercer; Xiawei Ou; Kori Mansfield; Robert Buchmann; Elisabet Børsheim; Emir Tas
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

2.  Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.

Authors:  Xuelian Zhou; Xiufu Lin; Jingnan Chen; Jiaqi Pu; Wei Wu; Zhaoyuan Wu; Hu Lin; Ke Huang; Li Zhang; Yangli Dai; Yan Ni; Guanping Dong; Junfen Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.